AGC’s Group Company in Southeast Asia Obtains International Sustainability and Carbon Certification, “ISCC PLUS Certification”
AGC (AGC Inc., Headquarters: Tokyo; President: Yoshinori Hirai) (TOKYO:5201), a world-leading manufacturer of glass, chemicals and other high-tech materials, has announced that its group company PT Asahimas Chemical (ASC, Headquarters: Indonesia), has recently obtained ISCC PLUS Certification*, one of the international certification systems for sustainable products. This certification confirms that biomass-derived raw materials and renewable raw materials (including those derived from renewable energy) are managed sustainably throughout the entire supply chain, including the manufacturing process, in accordance with ISCC standards, and that the traceability is ensured.
This certification enables ASC to handle ISCC PLUS-certified products such as Caustic soda, Vinyl chloride monomer (VCM), and Polyvinyl chloride resin (PVC), thereby strengthening its product portfolio. Additionally, ASC will be able to provide customers who are actively promoting sustainability with products that meet international standards. The following products in the Chemicals Segment of the AGC Group have currently obtained this certification.
Certified companies and sites | Representative products certified | Date of certification |
PT Asahimas Chemical
| Caustic soda
| June 2025 |
AGC Vinythai Public Company Limited
| Epichlorohydrin "EPINITY™" | July 2023 |
Under its long-term management strategy "Vision 2030", the AGC Group has set "Sustainability Management" as one of its key strategies. By providing these certified products, the Group will promote initiatives that reduce environmental impact throughout the entire value chain - from the procurement of raw materials to customer use - thereby contributing to the realization of a sustainable global environment.
[Remark]
* ISCC (International Sustainability and Carbon Certification) PLUS Certification
https://www.iscc-system.org/certification/iscc-certification-schemes/iscc-plus/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250727267568/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Neoadjuvant/Adjuvant NSCLC Treatment28.7.2025 12:00:00 CEST | Press release
Recommendation based on Phase 3 RATIONALE-315 study, in which TEVIMBRA demonstrated clinically meaningful and statistically significant improvement in event-free survival and major pathological responseIf approved, the expanded label builds on TEVIMBRA’s momentum in lung cancer with EU approvals already in NSCLC and SCLC indications across both first- and second-line settings BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending approval of TEVIMBRA® (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment and then continued as monotherapy as adjuvant treatment, for the treatment of adult patients with resectable non-small cell lung cancer (NSCLC) at high risk of recurrence. This recommendation is based on the Phase 3 RATIONALE-315 study (NCT04379635). “Patients with
L&T Technology Services Wins ~$60 Million Software Engineering Engagement From US Tier-I Telecom Provider28.7.2025 09:30:00 CEST | Press release
Multi-year win builds on decade-long partnership between LTTS and Client L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a global leader in engineering and technology services, today announced a major milestone in its Tech segment with the signing of a ~$60 million multi-year agreement with a prominent U.S. based provider of wireless telecommunications services. This strategic engagement will see LTTS delivering advanced network software development and application engineering solutions. Under the terms of the agreement, LTTS will provide crucial engineering services, including R&D lab integration, new product development, and functionality testing for the customer’s network software automation platforms. Additionally, LTTS will establish a delivery center in the United States to further support and enhance project delivery. The engagement will leverage LTTS’ capabilities in Smart World Connectivity and next generation networks to drive cutting-edge innovations for the client
Bureau Veritas Partners with IFC’s Building Resilience Index to Expand Resilience Verification Services Globally28.7.2025 08:00:00 CEST | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has signed the first global verifier agreement to expand the reach and impact of the Building Resilience Index (BRI). Under this agreement, Bureau Veritas will serve as a verification partner for BRI across key emerging markets in Latin America, Africa, and East Asia and the Pacific. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250727906462/en/ Marc Roussel, Executive Vice President, Urbanization & Assurance at Bureau Veritas An innovation of IFC, a member of the World Bank Group, BRI is a web-based framework designed to help developers, investors, and policymakers identify risks to buildings posed by natural hazards and assess, improve, and disclose their resilience. Through this partnership with Bureau Veritas, BRI users will gain greater access to high-quality, third-party verification of climate-resilient construction practices, e
The Open Group Launches The Open Group Open Digital Transformation™ Forum28.7.2025 08:00:00 CEST | Press release
Standards body aims to spur faster, more effective transformation initiatives The Open Group, the vendor-neutral technology consortium, has today announced the formation of The Open Group Open Digital Transformation™ Forum (ODXF). This new initiative will support enterprise Digital Transformation by developing and popularizing pragmatic, open standards in this increasingly valuable and challenging space. By establishing clear guidelines for Digital Transformation initiatives and enabling cross-industry collaboration to share insights and best practices, ODXF aims to ensure that a greater share of Digital Transformation investment globally delivers effective returns on investment and measurably positive impacts on cultural, workforce, and technological changes. “The vast majority of enterprises today are engaged in Digital Transformation initiatives, with significant global spend in Digital Transformation,” commented Rashed Al-Yami, Governing Board Member of The Open Group and Manager D
Azafaros Announces Initiation of two Global Phase 3 studies with Nizubaglustat in Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses, respectively28.7.2025 07:00:00 CEST | Press release
First patient dosed in global pivotal clinical trial program for late infantile/juvenile onset NPC and GM1/GM2 gangliosidoses.Both studies are part of Azafaros’ mission to develop treatments for the unmet need of patients with rare lysosomal storage disordersThe news follows the company’s recent successful €132M Series B financing, aimed at supporting the rapid development of nizubaglustat and the expansion of Azafaros’ pipeline to other indications Azafaros, a company focused on developing treatments for the unmet needs of patients with rare lysosomal storage disorders, today announced that the first patient has been dosed in the company’s pivotal, multicenter Phase 3 clinical program to evaluate the safety and efficacy of the company’s lead asset, nizubaglustat, in patients with Niemann-Pick disease Type C (NPC) and GM1/GM2 gangliosidoses. The initiation of the two Phase 3 studies (NCT07054515)represents a major milestone in Azafaros' commitment to addressing the urgent unmet medical
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom